Product Description
Emgrast 300 mcg Injection is a human granulocyte colony-stimulating factor (G-CSF) analog. It stimulates the growth of white blood cells and helps in decreasing the chances of infection in patients who are undergoing chemotherapy procedures for cancer. Patients with blood disorders are advised not to use this medicine.
Advancing Clinical Outcomes in NeutropeniaEmgrast Injection offers targeted support for patients experiencing reduced neutrophil counts due to chemotherapy, bone marrow transplantation, or HIV/AIDS. By utilizing recombinant human G-CSF, this formulation effectively helps restore white blood cell levels, enabling improved resistance against infections during critical periods. Its isotonic, latex-free, and preservative-free profile ensures safety and compatibility with most patients.
Ease and Assurance with Prefilled SyringeThe 1 ml single-use, prefilled syringe of Emgrast Injection provides ready-to-administer convenience, maintaining sterility and reducing preparation errors. Each pack includes an alcohol swab and detailed instructions, supporting seamless clinical administration by healthcare professionals. This design enhances safety and saves valuable time in urgent care scenarios.
FAQs of Emgrast Injection:
Q: How should Emgrast Injection 300 mcg be administered?
A: Emgrast Injection is delivered via subcutaneous or intravenous injection by a qualified healthcare professional. It must never be self-administered and should only be given under proper medical supervision.
Q: What is the main purpose of Emgrast Injection?
A: Emgrast Injection is primarily used to treat neutropenia (low neutrophil count) resulting from chemotherapy, bone marrow transplantation, or HIV/AIDS. It also aids in mobilizing progenitor stem cells for collection.
Q: When should Emgrast Injection be used during therapy?
A: Emgrast Injection is typically used after chemotherapy or stem cell transplant procedures, as directed by the treating physician, to assist in the rapid recovery of white blood cell counts and reduce infection risks.
Q: Where should Emgrast Injection be stored?
A: Store Emgrast Injection in a refrigerator at 2C to 8C. The product should be protected from light and must not be frozen to maintain stability and efficacy.
Q: What are the benefits of using Emgrast Injection?
A: Emgrast Injection significantly reduces the risk of infections by stimulating the bodys production of neutrophils (white blood cells), allowing patients to receive their planned chemotherapy cycles and improving overall treatment outcomes.
Q: What process is used in the production of Emgrast Injection?
A: Emgrast Injection is produced using recombinant DNA technology in E. coli bacteria, ensuring consistent purity and potency of the filgrastim protein.
Q: Is there any preservative or latex in Emgrast Injection?
A: No, Emgrast Injection is a preservative-free and latex-free product, minimizing the risk of allergic reactions and ensuring enhanced patient safety.